Publicacións (80) Publicacións de Juan Turnes Vázquez

2024

  1. Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: results of a Delphi study

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 337-346

  2. LiverAI: New tool in the landscape for liver health

    Gastroenterologia y Hepatologia

  3. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

    Alimentary Pharmacology and Therapeutics

  4. Recommendations for the future management of thrombocytopenia in patients with liver cirrhosis: A modified RAND/UCLA appropriateness method

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 1, pp. 32-50

  5. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

    Journal of Gastroenterology

2023

  1. Increasing and sustaining blood-borne virus screening in Spain and Portugal throughout the COVID-19 pandemic: a multi-center quality improvement intervention

    Frontiers in public health, Vol. 11, pp. 1268888

  2. Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 3, pp. 128-132

  3. Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver Disease

    Clinics in Liver Disease, Vol. 27, Núm. 2, pp. 515-533

  4. Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162

  5. Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B

    Digestive Diseases and Sciences, Vol. 68, Núm. 6, pp. 2731-2737

2022

  1. Estratexia para a eliminación da hepatite C como problema de saúde pública en Galicia

    Conselleria de Sanidade

  2. Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 5, pp. 342-349

2021

  1. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects

    Liver International, Vol. 41, Núm. 9, pp. 2076-2086

  2. Fecal incontinence and CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 593-598

  3. Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways

    Advances in Therapy

  4. Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy

    Clinics and Research in Hepatology and Gastroenterology, Vol. 45, Núm. 2

  5. Impacto clínico y económico global de la enfermedad hepática por hígado graso no alcohólico

    Revista Española de Enfermedades Digestivas, Vol. 113, Núm. 6, pp. 396-403

  6. Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review

    Scientific Reports, Vol. 11, Núm. 1

  7. Roadmap to resuming care for liver diseases after coronavirus disease-2019

    Journal of Gastroenterology and Hepatology (Australia), Vol. 36, Núm. 4, pp. 885-892

  8. Sharing knowledge on Hepatology in times of change, or, why you should be on Twitter

    Gastroenterologia y Hepatologia